Temporal lobe hypoperfusion in isolated amnesia with slow onset: A single photon emission computer tomography study

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 1, 2004, Pages 15-23

  Høgh, Peter ^a,b   Sjö, Nina Madsen ^a   Gade, Anders ^a   Waldemar, Gunhild ^a  

^a Mental Health Center Glostrup   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Amnesia; Mild cognitive impairment; Neuropsychology; Single photon emission computer tomography; Temporal lobe

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; AMNESIA; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN REGION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TEMPORAL LOBE;

ADULT; AGED; AGED, 80 AND OVER; AMNESIA; CEREBELLUM; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3042601069     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077730     Document Type: Article

References (43)

1. Waldemar G: Functional brain imaging with SPECT in normal aging and dementia. Cerebrovasc Brain Metab Rev 1995;7:89-130.
2. Claus JJ, van Harskamp F, Breteler MM, et al: The diagnostic value of SPECT with Tc99m HMPAO in Alzheimer's disease: A population based study. Neurology 1994;44:454-461.
3. 123I]-IBZM in Alzheimer's disease and dementia of frontal type: Preliminary results. Acta Neurol Scand 1994;89:199-203.
4. Jobst KA, Smith AD, Barker CS, et al: Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parieto-temporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-194.
5. 99mTc]-d,l-HMPAO SPECT-study. J Neurol Neurosurg Psychiatry 1994;57:285-295.
6. Reiman EM, Uecker A, Caselli RJ, et al: Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998;44:288-291.
7. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
8. Petersen RC, Smith GE, Ivnik RJ, et al: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memoryimpaired individuals. JAMA 1995;273:1274-1278.
9. Berent S, Giordani B, Foster N, et al: Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res 1999;33:7-16.
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
11. McKhann G, Drachmann D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work group. Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
12. Folstein MF, Folstein SE, McHugh PR: 'Minimental state': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Waldemar G, Bruhn P, Schmidt E, et al: Cognitive profiles and regional cerebral blood flow patterns in dementia of the Alzheimer type. Eur J Neurol 1994;1:81-89.
14. Strub RL, Black FW: The Mental Status Examination in Neurology, ed 3. Philadelphia, Davis,1993.
15. Buschke H, Fuld PA: Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 1974;24:1019-1025.
16. Andersen R: Verbal and visio-spatial memory: Two clinical tests administered to a group of normal subjects. Scand J Psychol 1976;17:198-204.
17. Spellacy FJ, Spreen O: A short form of the token test. Cortex 1969;5:391-397.
18. Poppelreuter W: Disturbances of Lower and Higher Visual Capacities Caused by Occipital Damage. Oxford, Oxford University Press,1990.
19. Gade A, Udesen H, Mortensen EL: Visual closure: Street completion test. Nordisk Psykologi 1988;40:194-201.
20. Waldemar G, Hasselbalch SG, Andersen AR, et al: 99mTc-d,l-HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metab 1991;11:508-521.
21. Johnson KA, Jones K, Holman BL, et al: Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
22. Hamilton D, O'Mahony D, Coffey J, et al: Classification of mild Alzheimer's disease by artificial neural network analysis of SPET data. Nucl Med Commun 1997;18:805-810.
23. O'Mahony D, Coffey J, Murphy J, et al: The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med 1994;35:1450-1455.
24. Holman BL, Johnson KA, Gerada B, Carvalho BA, Satlin A: The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:181-185.
25. Fazio F, Perani D, Gilardi MC, et al: Metabolic impairment in human amnesia: A PET study of memory networks. J Cereb Blood Flow Metab 1992;12:353-358.
26. Perani D, Bressi S, Cappa SF, et al: Evidence of multiple memory systems in the human brain. Brain 1993;116:903-919.
27. Lucchelli F, De Renzi E, Perani D, Fazio F: Primary amnesia if insidious onset with subsequent stabilisation. J Neurol Neurosurg Psychiatry 1994;57:1366-1370.
28. Ouchi Y, Nobezawa S, Okada H, Yoshikawa E, Futatsubashi M, Kaneko M: Altered glucose metabolism in the hippocampal head in memory impairment. Neurology 1998;51:136-142.
29. Miceli G, Colosimo C, Daniele A, Marra C, Perani D, Fazio F: Isolated amnesia with slow onset and stable course, without ensuing dementia: MRI and PET data and six-year neuropsychological follow-up. Dementia 1996;7:104-110.
30. Pietrini P, Azari NP, Grady NP, et al: Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: A longitudinal evaluation. Dementia 1993;4:94-101.
31. Kennedy A, Frackowiak R, Newman S, et al: Deficits in cerebral glucose metabolism demonstrated by PET in individuals at risk for familial Alzheimer's disease. Neurosci Lett 1995;186:17-20.
32. Claus JJ, Walstra GJM, Hijdra A, Van Royen EA, Verbeeten B Jr, van Gool WA: Measurement of temporal regional cerebral perfusion with single-photon emission tomography predicts rate of decline in language function and survival in early Alzheimer's disease. Eur J Nucl Med 1999;26:265-271.
33. Celsis P, Agniel A, Cardebat D, et al: Age related cognitive decline: A clinical entity? A longitudinal study of cerebral blood flow and memory performance. J Neurol Neursurg Psychiatry 1997;62:601-608.
34. Arnaiz E, Jelic V, Almkvist LO, et al: Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001;12:851-855.
35. Okamura N, Arai H, Maruyama M, et al: Combined analysis of CSF tau levels and [(123)I] iodoamphetamine SPECT in mild cognitive impairment: Implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002;159:474-476.
36. Schmidtke K, Reinhardt M, Krause T: Cerebral perfusion during transient global amnesia: Findings with HMPAO SPECT. J Nucl Med 1998;39:155-159.
37. Venneri A, Caffarra P: Transient autobiographic amnesia: EEG and single-photon emission CT evidence of an organic etiology. Neurology 1998;50:186-191.
38. Evans J, Wilson B, Wraight EP, Hodges JR: Neuropsychological and SPECT scan findings during and after transient global amnesia: Evidence for the differential impairment of remote episodic memory. J Neurol Neurosurg Psychiatry 1993;56:1227-1230.
39. Laloux P, Brichant C, Cauwe F, Decoster P: Technetium-99m HM-PAO single photon emission computed tomography imaging in transient global amnesia. Arch Neurol 1992;49:543-546.
40. Johnson KA, Holman BL, Rosen TJ, Nagel JS, English RJ, Growdon JH: Iofetamine I 123 single photon emission computer tomography is accurate in the diagnosis of Alzheimer's disease. Arch Intern Med 1990;150:752-756.
41. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
42. Kogure D, Matsuda H, Ohnishi T, et al: Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000;41:1155-1162.
43. Aupée AM, Desgranges B, Eustache F, et al: Voxel-based mapping of brain hypometabolism in permanent amnesia with PET. Neuroimage 2000;13:1164-1173.